. Skin biopsy from erythematous nodule on the leg showing a circumscribed area of fat necrosis prompted a change in therapy. Nicotinamide (initial dose 1.5 g daily, maximum dose 2.25 g daily) was tried for one month but failed to have any therapeutic effect. Mepacrine (dose 100 mg twice weekly) caused profound nausea and vomiting and was therefore withdrawn before its therapeutic potential could be assessed. Auranofin (dose 6 mg daily) was primarily prescribed for the rheumatoid arthritis which had become active, but therapy was accompanied by a 4-month period of inactivity of the panniculitis. The cutaneous disease relapsed during the last 2 months of gold therapy and cyclosporin A was then introduced (initial dose 1 mg/kglday, maximum dose 2 mg/kg/day). A therapeutic dose ofcyclosporin A was not achieved due to the onset of severe, resistant hypertension associated with doses in excess of 1.5 mg/kg/day. The panniculitis spread to involve the arms with similar tumid erythematous nodules which progressed to pustulation and then ulcerated. Azathioprine (initial dose 25 mg daily, maximum dose 100 mg daily), methotrexate (initial dose 2.5 mg/week, maximum dose 7.5 rug/week) and potassium iodide (initial dose 50 mg daily, maximum dose 500 mg three times daily) were tried in succession for 2 months, 2 months and 10 days respectively, but did not affect the steady progression of her cutaneous disease. Prednisolone (initial dose 30 mg daily, maximum dose 60 mg daily) therapy was accompanied by the rapid onset of marked cushingoid changes, steroid myopathy and subsequently opportunistic bronchopneumonia. Thalidomide (dose 100 mg twice daily) was prescribed for 4 months but caused nausea and vomiting and failed to halt the progression of the panniculitis.
Screening of our patient's serum identified a moderate level of circulating immune complexes. It was considered that these could be relevant to the development and maintenance of the panniculitis therefore plasmaphoresis was performed but appeared to make very little immediate difference. As part of the planned treatment, plasmaphoresis was followed by cyclophosphamide infusions with an initial dose of 1250 mg followed by 750 mg at 3-monthly intervals. Our patient has now received two such infusions and there has been a partial remission in her cutaneous disease with a significant reduction in deep pustulation.
Discussion
Adipose tissue may be involved as part of the inflammatory process of connective tissue in lupus erythematosus, scleroderma and dermatomyositis'. There are few reports of panniculitis occurring in rheumatoid arthritis 2 -4 Primary retroperitoneal neurilemmomas are rare tumours in the absence of Von Recklinghausen's disease. Fewer than 50 benign and 20 malignant cases have been described in the English literature. A patient is described presenting with vague upper abdominal symptoms who was found to have a 3 kg malignant retroperitoneal neurilemmoma associated with the pancreatic tail.
Case report
A 60-year-old man presented with a 6 week history of oesophageal regurgitation and post-prandial fullness. There had been no change in his bowel habit and his weight had been constant. On examination there was a large, firm nontender mass in the left upper quadrant that did not move with respiration. There were no cutaneous stigmata of neurofibromatosis.
A barium meal revealed a huge mass filling the lesser sac and displacing the stomach to the left (Figure 1 ). An ultrasound scan showed it to consist of cystic and solid elements and it was thought to arise from the tail of the pancreas. A CT scan confirmed the multicystic appearance of the lesion and no liver or lymph node metastases were evident. Fine needle aspiration cytology and CT guided are aware of no detailed case reports after Yaffee's case in 1955.
Many of the drugs used unsuccessfully in the treatment of our patient have been reported to be effective in the treatment of panniculitis. A discussion of such treatments is beyond the scope of this report but can be obtained from current authoritative textbooks", Clinical and histological features of our case are similar to those described in connective tissue panniculitis'. This seldom reported type of panniculitis follows a progressive course with chronic caseous necrosis of fat tissue, a lymphohistiocytic infiltrate and results in marked subcutaneous atrophy. Antimalarials have been reported to be effective in connective tissue panniculitis but previous intolerance precluded their use in our patient. 
